From 2014 to 2018, our research partners in Latin American and Caribbean cities gathered information from people who use or sell smokable cocaine, in order to identify key patterns in the regional markets of smokable cocaine. The information and testimonials we gathered reveal a lack of policy responses beyond punitive measures. Meanwhile, myths and misunderstandings about smokable cocaine and its users prevail. Read on below as we attempt to debunk the four most common myths.
Smokable cocaines are commonly referred to as “the most harmful drug”, and considered not just a threat to public health, but also to public security in the urban centres of many large cities. As a result, its users are frequently subject to hostility and stigmatization.
The 63rd Sesssion of the Commission on Narcotic Drugs takes place from 2nd to 6th March 2020. TNI and its partners will participate at this annual series of meetings and co-hosts five side events on 5th and 6th March 2020.
Societies in the Americas have coexisted with smokable cocaines for over four decades, but - surprisingly - there is a dearth of research on the development of the market, or much first-hand evidence of how this substance is actually commercialized and used by millions of people in the region. After a few years of field research, our study on the topic will be launched at the Commission on Narcotic Drugs.
From 15 to 18 November 2018, the Transnational Institute (TNI) and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH, on behalf of the German Federal Ministry for Economic Cooperation and Development (BMZ) jointly organised the 10th Asian Informal Drug Policy Dialogue (IDPD). It was organised in collaboration with the Central Committee for Drug Abuse Control (CCDAC) of Myanmar and held at Inle Lake, Southern Shan State, Myanmar.
Local and regional authorities across Europe are confronted with the negative consequences of a persisting illicit cannabis market. Increasingly, local and regional authorities, non-governmental pressure groups and grassroots movements are advocating a regulation of the recreational cannabis market.
Tom Blickman, Katie Sandwell, Dania Putri, Xabier Arana, Tom Decorte, Vibeke Asmussen Frank, Dirk J. Korf, Ingo Ilja Michels, Maj Nygaard-Christensen, Tim Pfeiffer-Gerschel, Heino Stöver, Bernd Werse, Frank Zobel
20 March 2019
In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.
This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches. Public Policy Exchange welcomes the participation of all key partners, responsible authorities and stakeholders. The Symposium will support the exchange of ideas and encourage delegates to engage in thought-provoking topical debate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Ecuador has entered a new era in drug policy and legislation. Twenty-five years after the last major legal reform, brought about by the famed Narcotic and Psychotropic Substances Law (Ley de Sustancias Estupefacientes y Psicotrópicas, Law 108), which took effect on September 17, 1990, the National Assembly is about to debate—for the second and final time—the draft Law on Prevention of Drugs and Use or Consumption of Substances Classified as Subject to Oversight (Ley de Prevención de Drogas y Uso y Consumo de Sustancias Catalogadas Sujetas a Fiscalización.)
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
In 2008, Harm Reduction International released the Global State of Harm Reduction, a report that mapped responses to drug-related HIV and hepatitis C epidemics around the world for the first time.(1) The data gathered for the report provided a critical baseline against which progress could be measured in terms of the international, regional and national recognition of harm reduction in policy and practice. Since then, the biennial report has become a key publication for researchers, policymakers, civil society organisations and advocates, mapping harm reduction policy adoption and programme implementation globally.
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.
Ernestien Jensema, Martin Jelsma, Tom Kramer, Tom Blickman
01 June 2014
TNI's indepth examination of the illegal drug market in the Golden Triangle, which has witnessed a doubling of opium production, growing prison populations and repression of small-scale farmers. This report details the failure of ASEAN's 'drug free' strategy and the need for a new approach.
The objective of this seminar is to compare the findings on innovative tools for the prevention of problematic cocaine use patterns, with experiences with harm reduction measures for stimulants in other regions of world.
Building on a long history and culture of tolerance, the Dutch responded to illicit drugs with decades of pragmatic measures free of judgment. A central element of modern Dutch drug policy was a crucial decision to establish a legal and practical separation of cannabis—judged to pose "acceptable" risks to consumers and society—from hard drugs associated with unacceptable risk. This policy effectively decriminalized possession and use of cannabis and opened the door for tolerated outlets for small-scale cannabis sales that eventually took the form of the well-known Dutch "coffee shops."